Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04987320
Status:
COMPLETED
Last Update Posted:
2023-09-25
First Post:
2021-07-26
Brief Title:
A Study to Evaluate the Pharmacokinetics Pharmacodynamics Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoproteina
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20190095
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None